Hydrocortisone butyrate is the butyrate salt form of hydrocortisone with the chemical name (11β)-11,17,21-trihydroxypregnan-4-ene-3,20-dione-17α-butyrate. It is a corticosteroid with anti-inflammatory, antipruritic and vasoconstrictive effects. Hydrocortisone butyrate is used to treat a variety of skin conditions, especially dermatitis. The structure is shown in fig. 1.
Fig. 1 Structure of hydrocortisone butyrate
Dermatitis is an inflammation of the skin typically characterized by itchiness, redness and a rash. In short-term cases, there may be small blisters, while the skin may thicken in long-term cases. There are several types of dermatitis, including atopic dermatitis, contact dermatitis, stasis dermatitis and seborrheic dermatitis. It was estimated that dermatitis affected 245 million people globally in 2015, about 3.34% of the world's population. Dermatitis can be treated with hydrocortisone butyrate.
Hydrocortisone butyrate has been available as a first-line therapy for inflammatory skin conditions since the 1950s. One study surveyed 89 patients (86 with chronic hand dermatitis and 3 with atopic dermatitis). Comparing the safety, efficacy, and cosmetic acceptability of 4 medium-potency topical corticosteroid products: hydrocortisone butyrate (HB) 0.1% cream, fluticasone propionate (FP) 0.05% cream, prednicarbate (PC) 0.1% cream, and mometasone furoate (MF) 0.1% cream. The results indicated comparable efficacy of all 4 medium-potency corticosteroid products, but HB 0.1% cream exhibits excellent soothing and moisturizing qualities. Therefore, HB is especially friendly to dermatitis patients with dry skin. Fig. 2 illustrates the results, with the largest percentage of subjects (61%) preferring HB to PC for better moisturizing[1].
Fig. 2 Percentage of subjects preferring study product as "more soothing" (A) and "better moisturizing" (B)
Hydrocortisone butyrate is a synthetic glucocorticoid. Binding and activation of the glucocorticoid result in the activation of lipocortin that inhibits cytosolic phospholipase A2. Lack of phospholipase A2 prevents the release of arachidonic acid, a precursor for inflammatory mediators prostaglandins and leukotrienes, thereby inhibiting inflammation. In addition, glucocorticoid also stimulates lipocortin-1 release into the extracellular space, where it binds to the leukocyte membrane receptors and inhibits various inflammations.
Common side effects of hydrocortisone butyrate mainly include:
Purpura
Paresthesia
Pruritus of skin
Erythema
Telangiectasia
Stinging of skin
Folliculitis
Skin rash
Skin atrophy
Alfa Chemistry offers high quality hydrocortisone butyrate. Please feel free to contact us for APIs or technical services.
Privacy Policy | Cookie Policy | Copyright © 2025 Alfa Chemistry. All rights reserved.